Eagle Veterinary Technology KRX:044960KOSDAQ

이글벳 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked8since Sep 11

In Q2 2026, Eagle Veterinary Technology reported revenue of ₩12.1bn, up 10.2% year on year, and operating profit of ₩1.7bn. Eagle Veterinary Technology (이글벳) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

Eagle Veterinary Technology quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩12.1bn+10.2%₩1.7bn
margin 14.4%
₩2.3bn
Q1 2026₩11.0bn+2.7%₩1.4bn
margin 12.4%
₩1.4bn
Q4 2025 derived₩11.1bn+7.9%₩1.1bn
margin 9.7%
₩1.3bn
Q3 2025₩10.5bn+5.9%₩286m
margin 2.7%
₩423m
Q2 2025₩11.0bn+0.6%₩1.6bn
margin 14.7%
₩1.1bn
Q1 2025₩10.7bn+1.3%₩1.3bn
margin 11.8%
₩1.1bn
Q4 2024 derived₩10.3bn+1.5%₩671m
margin 6.5%
₩1.1bn
Q3 2024₩9.9bn-5.0%₩626m
margin 6.3%
₩185m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Eagle Veterinary Technology top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Eagle Veterinary Technology news Korean headlines